Middle East & Africa active pharmaceutical ingredient market is projected to boom in the upcoming five years while exhibiting an impressive CAGR. In the last five years from 2016 to 2020 the market has experienced quite a growth that was counted in millions of sales, it is anticipated to project its growth in the forecast period, 2022-2026 on the account of surge in the demand of effective and efficient pharmaceutical products. The increasing instances of chronic diseases and complex treatment strategies is demanding the presence of active pharmaceutical ingredient, and the factor is actively driving the growth of the Middle East & Africa active pharmaceutical ingredient market in the upcoming five years. Moreover, advancing government initiatives and regulations for the active pharmaceutical ingredient production, along with the changes in the geopolitical changes are supporting the growth of the Middle East & Africa active pharmaceutical ingredient market in the next five years. Additionally, rapidly increasing research and development in the active pharmaceutical ingredient to enhance the quality and efficiency of the drugs they are part of, the market is anticipated to show a robust growth in the future five years of forecast. Furthermore, rapidly increasing number of market players in the region is responsible for the substantial future growth of the Middle East & Africa active pharmaceutical ingredient market in the forecast period, until 2026.

Any substance or combination of substances used in a finished pharmaceutical product (FPP), intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human beings is the textbook definition of active pharmaceutical ingredient (API).

The Middle East & Africa active pharmaceutical ingredient market is segmented by method of synthesis, source, therapeutic application, molecule type, potency, drug type, competitional landscape, and country distribution. Based on source, the market is divided between contact manufacturing organizations and in-house manufacturing. In-house manufacturing is anticipated to hold the larger revenue shares of the market and assert its dominance over the market on the account of easier availability of raw material in the manufacturing units as well as their compatibility with the drug production. Market players have actively taken initiatives for the in-house manufacturing and thereby supporting the growth of the market in the next five years. Although, contact manufacturing is expected to register the fastest growing CAGR in the upcoming years, since the countries like UAE, South Africa are actively involved in the contract based production of API.

Holding largest shares of market revenue, market players like Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd.,          Pfizer Inc., Dr. Reddy's Laboratories Ltd., Cipla Inc., Neopharma LLC, CAD Middle East Pharmaceutical Industries LLC, KMK Chemicals FZ LLC, Approcare Middle East,             AstraZeneca Plc., AbbVie Inc., Ketlaphela Pharmaceutical SOC Ltd, Afriplex (Pty) Ltd, Temad Co., Sanofi S.A., among others are actively involved with the research and development process of the active pharmaceutical ingredients in the region. Countries like Saudi Arabia, UAE, South Africa, have dedicated research labs for the advanced products development and consistent product modifications. Recent trend of efficient and effective pharmaceutical demands has enticed the market players to explore the area and come up with advanced products that would satisfy the emerging consumer demands.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze and forecast the market size of Middle East & Africa active pharmaceutical ingredient market from 2016 to 2019.
  • To estimate and forecast the market size of Middle East & Africa active pharmaceutical ingredient market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast Middle East & Africa active pharmaceutical ingredient market based on method of synthesis, source, therapeutic application, molecule type, potency, drug type, competitional landscape, and country distributions.
  • To identify dominant region or segment in the Middle East & Africa active pharmaceutical ingredient market.
  • To identify drivers and challenges for Middle East & Africa active pharmaceutical ingredient market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Middle East & Africa active pharmaceutical ingredient market.
  • To identify and analyze the profile of leading players operating in Middle East & Africa active pharmaceutical ingredient market.
  • To identify key sustainable strategies adopted by market players in Middle East & Africa active pharmaceutical ingredient market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of Middle East & Africa Active pharmaceutical ingredient market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers and other stakeholders
  • Organizations, forums, and alliances related to active pharmaceutical ingredients.
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Middle East & Africa active pharmaceutical ingredient market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

By (Biological v/s Synthetic) By Source () By Therapeutic Application () By Molecule Type () By Potency () By Drug Type ()

  • Middle East & Africa Active Pharmaceutical Ingredient Market, By Method of Synthesis:
    • Biological
    • Synthetic
  • Middle East & Africa Active Pharmaceutical Ingredient Market, By Source:

o   Contact Manufacturing Organizations

o   In-House Manufacturing

  • Middle East & Africa Active Pharmaceutical Ingredient Market, By Therapeutic Application:

o   Cardiovascular Diseases

o   Anti-diabetic Drugs

o   Oncology Drugs

o   Neurological Disorders

o   Musculoskeletal Disorders

o   Others

  • Middle East & Africa Active Pharmaceutical Ingredient Market, By Molecule Type:

o   Small

o   Large

  • Middle East & Africa Active Pharmaceutical Ingredient Market, By Potency:
    • Low
    • High
  • Middle East & Africa Active Pharmaceutical Ingredient Market, By Drug Type:
    • Innovator
    • Generics
  • Middle East & Africa Active pharmaceutical ingredient Market, By Country:
    • Saudi Arabia
    • UAE
    • Israel
    • Bahrain
    • South Africa
    • Nigeria
    • Egypt
    • Algeria
    • Morocco

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Middle East & Africa active pharmaceutical ingredient market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Middle East & Africa Active pharmaceutical ingredient Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Middle East & Africa Active Pharmaceutical Ingredients Market

4.    Executive Summary

5.    Voice of Customer

6.    Middle East & Africa Active Pharmaceutical Ingredients Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Method of Synthesis (Biological v/s Synthetic)

6.2.2.     By Source (Contact Manufacturing Organizations v/s In-House Manufacturing)

6.2.3.     By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others)

6.2.4.     By Molecule Type (Small v/s Large)

6.2.5.     By Potency (Low v/s High)

6.2.6.     By Drug Type (Innovator v/s Generics)

6.2.7.     By Country

6.2.8.     By Company (2020)

6.3.  Product Market Map

7.    Saudi Arabia Active Pharmaceutical Ingredients Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Method of Synthesis

7.2.2.     By Source

7.2.3.     By Therapeutic Application

7.2.4.     By Molecule Type

7.2.5.     By Potency

7.2.6.     By Drug Type

8.    UAE Active Pharmaceutical Ingredients Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Method of Synthesis

8.2.2.     By Source

8.2.3.     By Therapeutic Application

8.2.4.     By Molecule Type

8.2.5.     By Potency

8.2.6.     By Drug Type

9.     Israel Active Pharmaceutical Ingredients Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Method of Synthesis

9.2.2.     By Source

9.2.3.     By Therapeutic Application

9.2.4.     By Molecule Type

9.2.5.     By Potency

9.2.6.     By Drug Type

10.  Kuwait Active Pharmaceutical Ingredients Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Method of Synthesis

10.2.2.  By Source

10.2.3.  By Therapeutic Application

10.2.4.  By Molecule Type

10.2.5.  By Potency

10.2.6.  By Drug Type

11.  Bahrain Active Pharmaceutical Ingredients Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Method of Synthesis

11.2.2.  By Source

11.2.3.  By Therapeutic Application

11.2.4.  By Molecule Type

11.2.5.  By Potency

11.2.6.  By Drug Type

12.  South Africa Active Pharmaceutical Ingredients Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Method of Synthesis

12.2.2.  By Source

12.2.3.  By Therapeutic Application

12.2.4.  By Molecule Type

12.2.5.  By Potency

12.2.6.  By Drug Type

13.  Nigeria Active Pharmaceutical Ingredients Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Method of Synthesis

13.2.2.  By Source

13.2.3.  By Therapeutic Application

13.2.4.  By Molecule Type

13.2.5.  By Potency

13.2.6.  By Drug Type

14.  Egypt Active Pharmaceutical Ingredients Market Outlook

14.1.              Market Size & Forecast

14.1.1.  By Value

14.2.              Market Share & Forecast

14.2.1.  By Method of Synthesis

14.2.2.  By Source

14.2.3.  By Therapeutic Application

14.2.4.  By Molecule Type

14.2.5.  By Potency

14.2.6.  By Drug Type

15.  Algeria Active Pharmaceutical Ingredients Market Outlook

15.1.              Market Size & Forecast

15.1.1.  By Value

15.2.              Market Share & Forecast

15.2.1.  By Method of Synthesis

15.2.2.  By Source

15.2.3.  By Therapeutic Application

15.2.4.  By Molecule Type

15.2.5.  By Potency

15.2.6.  By Drug Type

16.  Morocco Active Pharmaceutical Ingredients Market Outlook

16.1.              Market Size & Forecast

16.1.1.  By Value

16.2.              Market Share & Forecast

16.2.1.  By Method of Synthesis

16.2.2.  By Source

16.2.3.  By Therapeutic Application

16.2.4.  By Molecule Type

16.2.5.  By Potency

16.2.6.  By Drug Type

17.  Market Dynamics

17.1.              Drivers

17.2.              Challenges

18.  Market Trends & Developments

19.  Competitive Landscape

19.1.              Competition Outlook

19.2.              Company Profiles (Includes SWOT Analysis)

19.2.1.  Teva Pharmaceutical Industries Ltd.

19.2.2.  Sun Pharmaceutical Industries Ltd.

19.2.3.  Pfizer Inc.

19.2.4.  Dr. Reddy's Laboratories Ltd.

19.2.5.  Cipla Inc.

19.2.6.  Neopharma LLC

19.2.7.  CAD Middle East Pharmaceutical Industries LLC

19.2.8.  KMK CHEMICALS FZ LLC

19.2.9.  Approcare Middle East

19.2.10.                AstraZeneca Plc.

19.2.11.                AbbVie Inc.

19.2.12.                Ketlaphela Pharmaceutical SOC Ltd

19.2.13.                Afriplex (Pty) Ltd

19.2.14.                Temad Co.

19.2.15.                Sanofi S.A.

20.  Strategic Recommendations

21.  About us & Disclaimer